Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
Prenetics reported Q1 2026 revenue of $36.0 million, driven by IM8 revenue of $33.8 million which grew nearly 6x year-over-year and 23% sequentially. The company raised its full-year 2026 IM8 revenue guidance to $190M-$210M, citing strong momentum with May 2026 monthly revenue hitting a record $16.7M, implying $200M in annualized recurring revenue. While the company reported a net loss of $23.1M, this was driven by non-cash fair-value losses on digital assets and warrants; core operating loss was $8.9M with gross margin expanding to 65%.
Key figures
- Revenue
- 35954000
- Guidance
- FY26 IM8 revenue $190M-$210M (raised from $180M-$200M); Q2 total revenue $46M-$48M
- Revenue Yoy
- 333%
- Gross margin
- 65%
- Gross profit
- 23283000
- Im8 revenue q1
- 33782000
- Im8 arr implied
- 200000000
- Im8 may revenue
- 16700000
- Im8 revenue seq
- 23.1%
- Im8 revenue yoy
- 489%
- Repurchase cost
- 19000000
- Im8 gross margin
- 64%
- Shares repurchased
- 968349
- Cash and equivalents
- 56017000
- Total liquidity may31
- 139700000
- Digital asset proceeds
- 41300000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.